Faros Mobile
Electrocardiograph, Ambulatory, With Analysis Algorithm. 510(k) K182030, from Bittium Biosignals , Ltd. (Kuopio, FI). Product code MLO, class 2.
As of Nov 17, 2026, K182030 is an FDA 510(k) held by Bittium Biosignals , Ltd., substantially equivalent on Nov 8, 2018 after 101 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Nov 8, 2018
- Review time: 101 days
- Recalls: 0
- Cited as a predicate by: 1 device
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe Faros Mobile system is intended for use in clinical long term ambulatory ECG monitoring, data transfer and analysis. Faros Mobile is indicated for adult and pediatric patients who require ECG monitoring inside or outside hospital or healthcare facility environments.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Cardiospy Ecg Holter SystemsK140847 · Labtech Kft. · Dec 5, 2014
Cited as a Predicate
1 later 510(k) summary names this device as a predicate- M5 RecorderK202456 · Global Instrumentation, LLC · Dec 29, 2020
Other MLO Clearances
The newest 510(k)s for the same product code; their median review was 231 days; see every MLO device- ZBPro Diagnostic (Version 2.0)K261580 · Zbeats, Inc. · Sep 11, 2026
- Philips Holter Analysis SystemK241890 · Philips Medizin Systeme Böblingen GmbH · Mar 21, 2025
- Frontier X PlusK240794 · Fourth Frontier Technologies Pvt, Ltd. · Nov 8, 2024
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Abbreviated
- Received
- Jul 30, 2018
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.2800
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files